somatostatin receptor

You have access
Identification of Wandering Masses and Tumor Heterogeneity on ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased Somatostatin Receptor Expression After Combined Chemotherapy and PRRT
Parth Baberwal, Rahul Parghane and Sandip Basu

Journal of Nuclear Medicine Technology September 1, 2024, 52 (3) 272-273; DOI: https://doi.org/10.2967/jnmt.123.267286
You have access
Metachronous Adenocarcinoma of the Lung in the Setting of Metastatic Gastric Neuroendocrine Tumor: Value of Elucidating Discordance on Dual-Tracer PET/CT with Ki-67 Index
Sarvesh Loharkar and Sandip Basu

Journal of Nuclear Medicine Technology March 1, 2023, 51 (1) 75-77; DOI: https://doi.org/10.2967/jnmt.121.263415
You have access
The Complementary Role of ⁶⁸Ga-DOTATATE PET/CT in Diagnosis of Recurrent Meningioma
Min J. Kong, Aaron F. Yang, Sujay A. Vora, Jeffrey S. Ross and Ming Yang

Journal of Nuclear Medicine Technology December 1, 2022, 50 (4) 348-352; DOI: https://doi.org/10.2967/jnmt.122.263949
You have access
Practical Considerations for Implementation of ¹⁷⁷Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa and Stephen A. Graves

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 195-202; DOI: https://doi.org/10.2967/jnmt.122.263813
You have access
Can ⁶⁸Ga-DOTA Peptides Be Potential Radiotracers for PET Imaging of the Spleen?
Ismet Sarikaya, Abdelhamid H. Elgazzar, Ali Sarikaya, Naheel Alnafisi and Saud Alenezi

Journal of Nuclear Medicine Technology June 1, 2018, 46 (2) 133-135; DOI: https://doi.org/10.2967/jnmt.117.203448

Main menu

User menu

Search

somatostatin receptor